Have to say, these guys have me interested.
I can see the similarities with PAR with the challenges with the FDA along the way and the impact to sp etc.That aside, what they are planning with CAR-T for kidney cancer could be awesome.
I wish them well and hopefully the FDA fast track has them back on the track onwards and upwards, although no immediate kick in SP today.
Certainly, one to watch (in my opinion)
research reports and media, page-2597
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
26.0¢ |
Change
0.010(4.00%) |
Mkt cap ! $91.06M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 26.0¢ | 25.0¢ | $36.40K | 143.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 40816 | 24.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 44646 | 4 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| PAR (ASX) Chart |